受强制性开放获取政策约束的文章 - Carl Eriksson了解详情
可在其他位置公开访问的文章：13 篇
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study
A Moens, CJ van der Woude, M Julsgaard, E Humblet, J Sheridan, ...
Alimentary pharmacology & therapeutics 51 (1), 129-138, 2020
强制性开放获取政策： Research Foundation (Flanders)
Systemic inflammation in preclinical ulcerative colitis
D Bergemalm, E Andersson, J Hultdin, C Eriksson, ST Rush, R Kalla, ...
Gastroenterology 161 (5), 1526-1539. e9, 2021
强制性开放获取政策： Swedish Research Council, UK Medical Research Council
Changes in medical management and colectomy rates: a population‐based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963‐2010
C Eriksson, Y Cao, S Rundquist, Y Zhulina, I Henriksson, S Montgomery, ...
Alimentary pharmacology & therapeutics 46 (8), 748-757, 2017
强制性开放获取政策： Swedish Research Council
The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
S Shrestha, O Olén, C Eriksson, ÅH Everhov, P Myrelid, I Visuri, ...
Scandinavian Journal of Gastroenterology 55 (4), 430-435, 2020
强制性开放获取政策： European Commission
Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study
C Eriksson, I Henriksson, O Brus, Y Zhulina, N Nyhlin, C Tysk, ...
Alimentary pharmacology & therapeutics 48 (6), 638-645, 2018
强制性开放获取政策： Swedish Research Council
Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study
C Eriksson, S Rundquist, Y Cao, S Montgomery, J Halfvarson
Gut 68 (4), 623-632, 2019
强制性开放获取政策： Swedish Research Council
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study
C Eriksson, S Rundquist, V Lykiardopoulos, R Udumyan, P Karlén, O Grip, ...
Therapeutic advances in gastroenterology 14, 17562848211023386, 2021
强制性开放获取政策： US Department of Energy
I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease
L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ...
Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023
强制性开放获取政策： US National Institutes of Health
Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease
L Bodecker-Zingmark, L Widbom, J Hultdin, C Eriksson, P Karling
Digestive Diseases and Sciences 68 (2), 608-615, 2023
强制性开放获取政策： Swedish Research Council
Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
C Eriksson, J Söderling, S Karlqvist, G Bröms, ÅH Everhov, D Bergemalm, ...
Digestive Diseases and Sciences 68 (7), 3119-3128, 2023
强制性开放获取政策： Swedish Research Council
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study
C Eriksson, J Sun, M Bryder, G Bröms, ÅH Everhov, A Forss, T Jernberg, ...
Alimentary Pharmacology & Therapeutics 59 (9), 1122-1133, 2024
强制性开放获取政策： Swedish Research Council
Preclinical Protein Signatures of Crohn’s Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts
O Grännö, D Bergemalm, B Salomon, CM Lindqvist, CRH Hedin, ...
Gastroenterology, 2024
强制性开放获取政策： European Commission
Spondyloarthritis in first-degree relatives and spouses of patients with inflammatory bowel disease: A nationwide population-based cohort study from Sweden
S Shrestha, JS Brand, M Osooli, C Eriksson, I Schoultz, J Askling, T Jess, ...
Journal of Crohn's and Colitis, jjae041, 2024
强制性开放获取政策： Danish National Research Foundation, Swedish Research Council, European …
出版信息和资助信息由计算机程序自动确定